Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease

NCT05439369 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05439369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
January 1, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

valvular heart disease stenosis and regurgitation